+Compare
AKU
Stock ticker:
NASDAQ
AS OF
Jun 30, 12:11 PM (EDT)
Price
$0.62
Change
+$0.02 (+3.33%)
Capitalization
53.7M

AKU Price Prediction, Akumin AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Jun 06, 2022

AKU in +5.63% Uptrend, rising for three consecutive days on May 31, 2022

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where AKU advanced for three days, in 40 of 60 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 35 cases where AKU's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 06, 2022. You may want to consider a long position or call options on AKU as a result. In of 48 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Bearish Trend Analysis

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.711) is normal, around the industry mean (7.078). P/E Ratio (0.000) is within average values for comparable stocks, (92.828). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.135). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. P/S Ratio (0.090) is also within normal values, averaging (92.060).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AKU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AKU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

AKU is expected to report earnings to fall 35.91% to -22 cents per share on August 17

Akumin AKU Stock Earnings Reports
Q2'22
Est.
$-0.22
Q1'22
Missed
by $0.08
Q4'21
Missed
by $0.09
Q3'21
Beat
by $0.41
Q2'21
Missed
by $0.02
The last earnings report on May 10 showed earnings per share of -34 cents, missing the estimate of -26 cents. With 10.88K shares outstanding, the current market capitalization sits at 53.70M.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Edwards Lifesciences Corp (NYSE:EW), Boston Scientific Corp (NYSE:BSX), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 5.65B. The market cap for tickers in the group ranges from 775 to 3.78T. MKYSF holds the highest valuation in this group at 3.78T. The lowest valued company is BIIO at 775.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -0%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was -26%. NRCD experienced the highest price growth at 2,122%, while SSSGY experienced the biggest fall at -46%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 23%. For the same stocks of the Industry, the average monthly volume growth was 34% and the average quarterly volume growth was 27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 61
SMR Rating: 69
Profit Risk Rating: 83
Seasonality Score: 14 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

a company, which engages in the provision of outpatient diagnostic imaging services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
8300 W. Sunrise Boulevard
Phone
+1 954 678-4489
Employees
3859
Web
https://www.akumin.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APEI15.680.22
+1.42%
American Public Education
GIFI3.250.01
+0.31%
Gulf Island Fabrication
ROAD20.34-0.08
-0.39%
Construction Partners
SRCL43.36-0.39
-0.89%
Stericycle
KLAC320.57-9.52
-2.88%
KLA Corp

AKU and Stocks

Correlation & Price change

A.I.dvisor tells us that AKU and SDC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKU and SDC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKU
1D Price
Change %
AKU100%
+6.54%
SDC - AKU
27%
Poorly correlated
-4.72%
ISR - AKU
26%
Poorly correlated
+5.44%
EKSO - AKU
26%
Poorly correlated
-0.57%
BIOC - AKU
25%
Poorly correlated
+1.69%
TLIS - AKU
23%
Poorly correlated
-2.27%
More